CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful. A limiting factor of this otherwise very effective and safe therapy is that the cells used in the process quickly reach a state of exhaustion. CAR-T cells are one of the personalized cancer therapies and have been used in specialized centers in Europe since 2018. In this complex treatment, immune cells, or more precisely T cells, are taken from the blood of cancer patients, genetically engineered in the laboratory with a chimeric antigen receptor (CAR) and then re-administered.
Related Posts
Adding sugar to coffee, tea may not significantly impact health
Adding sugar to coffee or tea may not significantly impact health when consumed in moderation. While excess sugar intake is associated with various health concerns such as obesity and diabetes, the amount typically added to individual servings of coffee or tea is relatively small. Consuming a reasonable amount of sugar as part of a balanced […]
How Poxviruses Such As Smallpox Evade the Immune System
Scientists have uncovered important new information about a key protein that allows viruses such as smallpox to replicate and wreak havoc on the immune system. The findings further our understanding of how the pox family of viruses works to subvert the immune system, the researchers say. They also believe their work could one day be […]
Blocking immune system ‘messenger’ may treat severe asthma
Asthma is more dangerous than many people realize. An estimated 10 Americans die every day from asthma, and the disease leads to around 439,000 hospitalizations and 1.3 million emergency room trips each year. Immune cells work as a team, and they secrete molecules to “talk” to each other. One of these molecular messengers is HRF, […]